Prof. Dr. Anja Lux

Professur für Integrated Immunology Lehrstuhl für Genetik

Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis (2014) Toh ML, Bonnefoy JY, Accart N, Cochin S, Pohle S, Haegel H, De Meyer M, et al. Journal article A humanized mouse identifies the bone marrow as a niche with low therapeutic IgG activity (2014) Lux A, Seeling M, Baerenwaldt A, Lehmann B, Schwab I, Repp R, Meidenbauer N, et al. Journal article How immunoglobulin G antibodies kill target cells: Revisiting an old paradigm (2014) Biburger M, Lux A, Nimmerjahn F Authored book, Volume of book series Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. (2013) Seeling M, Hillenhoff U, David JP, Schett G, Tuckermann J, Lux A, Nimmerjahn F Journal article Impact of immune complex size and glycosylation on IgG binding to human FcγRs. (2013) Lux A, Yu X, Scanlan CN, Nimmerjahn F Journal article Of mice and men: the need for humanized mouse models to study human IgG activity in vivo. (2013) Lux A, Nimmerjahn F Journal article, Review article The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. (2012) Böhm S, Schwab I, Lux A, Nimmerjahn F Journal article, Review article FcγRIIB: A modulator of cell activation and humoral tolerance (2012) Lehmann B, Schwab I, Böhm S, Lux A, Biburger M, Nimmerjahn F Journal article, Review article Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo. (2011) Bärenwaldt A, Lux A, Danzer H, Spriewald BM, Ullrich E, Heidkamp GF, Dudziak D, Nimmerjahn F Journal article Impact of differential glycosylation on IgG activity (2011) Lux A, Nimmerjahn F Conference contribution